[Multidrug resistance in hematological malignancies: prognostic significance and the effect of resistance-modulating drugs].
Sonneveld
P
P
Academisch Ziekenhuis Rotterdam-Dijkzigt, afd. Hematologie.
te Boekhorst
P A
PA
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents / Q000378:metabolism*; D002352:Carrier Proteins / Q000235:genetics; D004351:Drug Resistance; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000235:genetics*; D008562:Membrane Glycoproteins / Q000235:genetics; D009101:Multiple Myeloma / Q000188:drug therapy / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics; D011379:Prognosis
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins
Multidrug-resistentie in hematologische maligniteiten: prognostische betekenis en het effect van resistentie-modulerende farmaca.